Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Treasury Shares (2023 - 2025)

Xenetic Biosciences' Treasury Shares history spans 4 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, changed 0.0%, while the annual FY2025 figure was $5.3 million, 0.0% changed from the prior year.
  • Treasury Shares reached $5.3 million in Q4 2025 per XBIO's latest filing, roughly flat from $5.3 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $5.3 million in Q1 2023 to a low of $5.3 million in Q1 2023.
  • Average Treasury Shares over 3 years is $5.3 million, with a median of $5.3 million recorded in 2023.
  • The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $5.3 million in 2023, then changed by 0.0% to $5.3 million in 2024, then changed by 0.0% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Treasury Shares are $5.3 million (Q4 2025), $5.3 million (Q3 2025), and $5.3 million (Q2 2025).